Related Experiment Video
Updated: May 7, 2025
Comparative Lesions Analysis Through a Targeted Sequencing Approach
Published on: November 5, 2019
Mutational Profiling of Korean Lymphomas and Diffuse Large B-Cell Lymphoma Subtype Classification Using Targeted
Gilsung Yoo1, Jooyoung Cho1, Hyeong Ju Kwon2
1Department of Laboratory Medicine, Yonsei University Wonju College of Medicine, Wonju, South Korea.
Background:
Lymphoma is a common hematological malignancy with diverse morphological and immunophenotypic characteristics that may affect treatment and outcomes. Thus, accurate differential diagnosis is crucial, and molecular genetic testing is valuable. We aimed to investigate the genetic characteristics of Korean patients with lymphoma using a next-generation sequencing (NGS)-based targeted panel.
Methods:
We designed a panel covering 588 genes clinically and diagnostically relevant in lymphoma through a literature review and performed targeted panel sequencing of 34 formalin-fixed paraffin-embedded samples from patients with lymphoma.
Results:
Among the 34 samples examined, diffuse large B-cell lymphoma (DLBCL) was the most common, followed by NK/T-cell lymphoma, peripheral T-cell lymphoma, anaplastic large cell lymphoma, T-lymphoblastic leukemia/lymphoma, MALT lymphoma, and mantle cell lymphoma. The genes TP53, MYD88, CD79B, FOXO1, KMT2D, MYD88, TNFRSF14, and TET2 had the highest number of mutations. For patients with DLBCL, we used modified genetic subtype classification algorithms from previous studies and successfully classified 31.3-50% of them into specific subtypes. Notably, four patients were allocated a distinct subtype across all algorithms.
Conclusions:
Our targeted panel sequencing can effectively reveal lymphoma mutational profiles of samples in clinical settings and partially outline the mutational landscape of lymphomas in the Korean population, particularly DLBCL.
More Related Videos
13:24Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
11:15Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016